These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 23769799)
1. Aflibercept for the treatment of refractory polypoidal choroidal vasculopathy. Yonekawa Y Can J Ophthalmol; 2013 Jun; 48(3):e59-60. PubMed ID: 23769799 [No Abstract] [Full Text] [Related]
2. Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy. Morimoto M; Matsumoto H; Mimura K; Akiyama H Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1891-1897. PubMed ID: 28669041 [TBL] [Abstract][Full Text] [Related]
3. Resolution of persistent pigment epithelial detachment secondary to polypoidal choroidal vasculopathy in response to Aflibercept. Cheung CM; Mohla A; Wong TY Eye (Lond); 2014 Sep; 28(9):1148-9. PubMed ID: 24833182 [No Abstract] [Full Text] [Related]
5. One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy. Yamamoto A; Okada AA; Kano M; Koizumi H; Saito M; Maruko I; Sekiryu T; Iida T Ophthalmology; 2015 Sep; 122(9):1866-72. PubMed ID: 26088619 [TBL] [Abstract][Full Text] [Related]
6. Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy. Sakai T; Kato N; Kubota M; Tsuneoka H Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1565-1571. PubMed ID: 28601912 [TBL] [Abstract][Full Text] [Related]
7. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy. Ueno C; Gomi F; Sawa M; Nishida K Retina; 2012; 32(10):2006-13. PubMed ID: 22772392 [TBL] [Abstract][Full Text] [Related]
8. One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Matsumiya W; Honda S; Otsuka K; Miki A; Nagai T; Imai H; Kusuhara S; Nakamura M Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):541-548. PubMed ID: 27687988 [TBL] [Abstract][Full Text] [Related]
9. Optic disk melanocytoma associated with polypoidal choroidal vasculopathy lesions, after combination treatment of photodynamic therapy and intavitreal aflibercept (Eylea), a case report. Rouvas A; Gouliopoulos NS; Moschos MM; Theodossiadis P BMC Ophthalmol; 2018 Oct; 18(1):267. PubMed ID: 30309335 [TBL] [Abstract][Full Text] [Related]
10. Association between the arm-to-choroidal circulation time and clinical profile in patients with polypoidal choroidal vasculopathy. Mukai R; Itagaki K; Honjyo J; Tanaka K; Norikawa K; Sekiryu T Jpn J Ophthalmol; 2024 May; 68(3):211-215. PubMed ID: 38609716 [TBL] [Abstract][Full Text] [Related]
11. Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy. Hosokawa M; Shiraga F; Yamashita A; Shiragami C; Ono A; Shirakata Y; Kimura S; Shiode Y; Kawata T; Hosogi M; Fujiwara A; Morizane Y Br J Ophthalmol; 2015 Aug; 99(8):1087-91. PubMed ID: 25712826 [TBL] [Abstract][Full Text] [Related]
12. ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY. Hara C; Sawa M; Sayanagi K; Nishida K Retina; 2016 Jan; 36(1):37-45. PubMed ID: 26383709 [TBL] [Abstract][Full Text] [Related]
13. CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY. Sakurada Y; Sugiyama A; Tanabe N; Kikushima W; Kume A; Iijima H Retina; 2017 Oct; 37(10):1866-1872. PubMed ID: 28002268 [TBL] [Abstract][Full Text] [Related]
19. Aflibercept Treatment in Polypoidal Choroidal Vasculopathy: Results of a Prospective Study in a Caucasian Population. Wolff B; Vasseur V; Cahuzac A; Coscas F; Castelnovo L; Favard C; Michel G; Français C; Salomon L; Mauget-Faÿsse M Ophthalmologica; 2018; 240(4):208-212. PubMed ID: 29804123 [TBL] [Abstract][Full Text] [Related]
20. REDUCED VASCULAR DENSITY IN THE CHOROID AFTER TREATMENT WITH PHOTODYNAMIC THERAPY COMBINED WITH AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY. Mukai R; Matsumoto H; Miyakubo T; Akiyama H Retina; 2021 Jan; 41(1):156-161. PubMed ID: 32251239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]